• No results found

[PDF] Top 20 FORMULATION AND OPTIMIZATION OF BUPROPION HCl MICROSPONGES BY 23 FACTORIAL DESIGN

Has 10000 "FORMULATION AND OPTIMIZATION OF BUPROPION HCl MICROSPONGES BY 23 FACTORIAL DESIGN" found on our website. Below are the top 20 most common "FORMULATION AND OPTIMIZATION OF BUPROPION HCl MICROSPONGES BY 23 FACTORIAL DESIGN".

FORMULATION AND OPTIMIZATION OF BUPROPION HCl MICROSPONGES BY 23 FACTORIAL DESIGN

FORMULATION AND OPTIMIZATION OF BUPROPION HCl MICROSPONGES BY 23 FACTORIAL DESIGN

... optimised formulation was ...Optimised formulation F10 followed first order release and Higuchi ...of Bupropion HCl in Microsponge formation and DCM as a solvent showed sustained release ... See full document

11

FORMULATION DEVELOPMENT OF VALSARTAN TABLETS EMPLOYING ? CD, CROSPOVIDONE AND SLS: OPTIMIZATION BY 23 FACTORIAL DESIGN

FORMULATION DEVELOPMENT OF VALSARTAN TABLETS EMPLOYING ? CD, CROSPOVIDONE AND SLS: OPTIMIZATION BY 23 FACTORIAL DESIGN

... tablet formulation employing βCD, Crospovidone and SLS by 2 3 Factorial design to achieve NLT 85% dissolution in 10 ...For optimization of Valsartan tablets as per 2 3 Factorial ... See full document

9

FORMULATION OF TELMISARTAN TABLETS EMPLOYING βCD, CROSPOVIDONE, POLOXAMER   OPTIMIZATION BY 23 FACTORIAL DESIGN

FORMULATION OF TELMISARTAN TABLETS EMPLOYING βCD, CROSPOVIDONE, POLOXAMER OPTIMIZATION BY 23 FACTORIAL DESIGN

... its formulation development to derive its maximum therapeutic ...tablet formulation by 2 3 factorial design to achieve NLT 85% dissolution in 10 ... See full document

9

OPTIMIZATION OF TELMISARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN  EMPLOYING βCD, PRIMOJEL AND TWEEN 80

OPTIMIZATION OF TELMISARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING βCD, PRIMOJEL AND TWEEN 80

... a formulation whose attributes confirm with certain prerequisite ...new formulation shall be on a rational basis. The application of formulation optimization techniques is relatively new to ... See full document

6

FORMULATION AND EVALUATION OF CAPTOPRIL FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN

FORMULATION AND EVALUATION OF CAPTOPRIL FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN

... is optimization of captopril floating tablet formulation by 2 3 factorial ...3 factorial design. The three factors involved in the 2 3 factorial design are sodium ... See full document

13

OPTIMIZATION OF TELMISARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING HPβCD, PRIMOJEL AND TWEEN 80Lakshmanarao.P , Chowdary K.P.R*and Prasad S.V.U.MDOWNLOAD/VIEW

OPTIMIZATION OF TELMISARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING HPβCD, PRIMOJEL AND TWEEN 80Lakshmanarao.P , Chowdary K.P.R*and Prasad S.V.U.MDOWNLOAD/VIEW

... D. Formulation Develpoment and Optimization of Loratidine Tablets Employing Solid Dispersions in MCC pH102 and Poloxamer188 as Per 2 2 Factorial ... See full document

7

Formulation and optimization of carbamazepine floating tablets by 23 - factorial design employing Starch-Urea-Borate: A new floating polymer

Formulation and optimization of carbamazepine floating tablets by 23 - factorial design employing Starch-Urea-Borate: A new floating polymer

... factorial design. ANOVA of floating times (Table 8) indicated that the individual effects of sodium bicarbonate (A), ethyl cellulose (B) and bees wax (C) as well as the combined effects of all the three ... See full document

11

FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN

FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN

... In the present study sustained release floating tablets of losartan potassium were formulated employing HPMC K15M (50 %) as matrix forming polymer, sodium bicarbonate as gas generating agent and beeswax and ethyl ... See full document

13

OPTIMIZATION OF VALSARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN

OPTIMIZATION OF VALSARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN

... a formulation whose attributes confirm with certain prerequisite ...new formulation shall be on a rational basis. The application of formulation optimization techniques is relatively new to ... See full document

10

OPTIMIZATION OF VALSARTAN TABLET FORMULATION BY  23 FACTORIAL DESIGN

OPTIMIZATION OF VALSARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN

... tablet formulation significantly influence dissolution rate and consequently bioavailability of the drug requiring a rational selection of diluents, binder and disintegrant ...tablet formulation by 2 3 ... See full document

6

FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN, IN VITRO AND PHARMACOKINETIC EVALUATION

FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN, IN VITRO AND PHARMACOKINETIC EVALUATION

... For optimization of valsartan tablets as per 2 3 Factorial designs the βCD, Crospovidone and SLS are considered as the three ...3 Factorial design were formulated and were prepared by direct ... See full document

12

OPTIMIZATION OF IRBESARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING ? CD, CROSPOVIDONE AND SLS

OPTIMIZATION OF IRBESARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING ? CD, CROSPOVIDONE AND SLS

... www.wjpr.net Vol 4, Issue 2, 2015. 1595 Several techniques [2] such as micronisation, cyclodextrin-complexation, use of surfactants, solubilizers and super disintegrants, solid dispersion in water soluble and water ... See full document

9

Design, Optimization and Evaluation of Piroxicam Fast Dissolving Tablets Employing Modified Starch by 23 Factorial Design.

Design, Optimization and Evaluation of Piroxicam Fast Dissolving Tablets Employing Modified Starch by 23 Factorial Design.

... Fast dissolving tablet have potential advantages over conventional dosage forms, which has helped patient compliance, convenience, bioavailability and rapid onset of action. These are very good for drug delivery over ... See full document

12

FORMULATION AND EVALUATION OF TOPICAL MICROSPONGES OF SERTACONAZOLE

FORMULATION AND EVALUATION OF TOPICAL MICROSPONGES OF SERTACONAZOLE

... topical formulation with control relase of drug, reducing the side effects associated with topical drug delivery and improve the efficacy of product with aid of ...containing microsponges loaded with ... See full document

18

A STUDY ON FEASIBILITY OF OPTIMIZATION TECHNIQUE IN FORMULATION OF DISPERSIBLE TABLETS BY FACTORIAL DESIGN

A STUDY ON FEASIBILITY OF OPTIMIZATION TECHNIQUE IN FORMULATION OF DISPERSIBLE TABLETS BY FACTORIAL DESIGN

... of formulation variables on Hardness (H) of tablets with CPVP as binder: The determined H values were represented in Table ...20. Design and Summary Response Data was represented in Table ...Table 23 ... See full document

20

FORMULATION AND EVALUATION OF DRY NASAL MUCOADHESIVE POWDER OF DESMOPRESSIN ACETATE BY USING 32 FULL FACTORIAL DESIGN

FORMULATION AND EVALUATION OF DRY NASAL MUCOADHESIVE POWDER OF DESMOPRESSIN ACETATE BY USING 32 FULL FACTORIAL DESIGN

... optimized formulation was subjected to particle size, % yield, mucoadhesive strength, % drug content, scanning electron microscopy, differential scanning calorimetry, ex vivo drug diffusion study, nasal toxicity ... See full document

18

DESIGN AND EVALUATION OF BILAYERED MUCOADHESIVE FILM OF CEFPODOXIME PROXETIL

DESIGN AND EVALUATION OF BILAYERED MUCOADHESIVE FILM OF CEFPODOXIME PROXETIL

... INTRODUCTION: The oral route of drug administration, although has many advantages, suffers from the limitation for dugs with short half- life. Due to the fast elimination of the drug from the gastric region there is an ... See full document

8

FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF GLICLAZIDE USING 23 FULL FACTORIAL DESIGN

FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF GLICLAZIDE USING 23 FULL FACTORIAL DESIGN

... The thickness of the tablet of each formulation ranges from 2.75±0.05-4.43±0.08 the measured hardness of tablets of each batch ranged from 4.0±0.13-5.60±0.5 kg/cm2 This ensures good handling characteristics of all ... See full document

12

Formulation design, optimization and in vivo evaluation of a ph and ion responsive ophthalmic in situ gel of forskolin  beta cyclodextrin complex

Formulation design, optimization and in vivo evaluation of a ph and ion responsive ophthalmic in situ gel of forskolin beta cyclodextrin complex

... All the formulations were found to be clear in appearance. The pH was within the acceptable range and hence would not cause any irritation when administered into the eye. The drug content was found to be in acceptable ... See full document

11

FORMULATION OF RITONAVIR TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN

FORMULATION OF RITONAVIR TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN

... is optimization of ritonavir tablet formulation employing βCD and Soluplus by 2 2 factorial ...design. Formulation of ritonavir tablets with NLT 85% dissolution in 15 min employing βCD ... See full document

9

Show all 10000 documents...